Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Unveiling the Kinomes of Leishmania infantum and L. braziliensis Empowers the Discovery of New Kinase Targets and Antileishmanial Compounds. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2007 · External reference
Unresolved reference
1987 · External reference
Unresolved reference
2005 · External reference
Leishmaniasis
10.1016/j.jinf.2014.07.016 · 2014 · External reference
Unresolved reference
External reference
Leishmaniasis worldwide and global estimates of its incidence
10.1371/journal.pone.0035671 · 2012 · External reference
10.1016/s1995-7645(12)60084-4
10.1016/s1995-7645(12)60084-4 · External reference
10.1021/cr500365f
10.1021/cr500365f · External reference
Unresolved reference
2005 · External reference
Protein kinases as drug targets in trypanosomes and Leishmania
10.1016/j.bbapap.2005.08.018 · 2005 · External reference
10.1038/nrd773
10.1038/nrd773 · External reference
10.1111/bph.13096
10.1111/bph.13096 · External reference
Unresolved reference
2005 · External reference
10.1126/science.1075762
10.1126/science.1075762 · External reference
10.1096/fasebj.9.8.7768349
10.1096/fasebj.9.8.7768349 · External reference
10.1016/j.pbiomolbio.2009.12.009
10.1016/j.pbiomolbio.2009.12.009 · External reference
Unresolved reference
2007 · External reference
Targeting protein kinases
2004 · External reference
Defining the Schistosoma haematobium kinome enables the prediction of essential kinases as anti-schistosome drug targets
10.1038/srep17759 · 2015 · External reference
Unresolved reference
2013 · External reference
Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi
10.1186/1471-2164-6-127 · 2005 · External reference
Unresolved reference
2003 · External reference
Unresolved reference
2002 · External reference
10.1093/nar/gkh340
10.1093/nar/gkh340 · External reference
10.1093/bioinformatics/btp163
10.1093/bioinformatics/btp163 · External reference
Unresolved reference
2017 · External reference
Unresolved reference
2010 · External reference
Unresolved reference
1990 · External reference
Unresolved reference
2015 · External reference
BioSystems CytoNCA : a cytoscape plugin for centrality analysis and evaluation of protein interaction networks
10.1016/j.biosystems.2014.11.005 · 2015 · External reference
10.1093/nar/gkx1037
10.1093/nar/gkx1037 · External reference
Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections
10.1093/jac/dkn509 · 2008 · External reference
10.1093/jac/dkm219
10.1093/jac/dkm219 · External reference
Heme uptake mediated by LHR1 is essential for Leishmania amazonensis virulence
10.1128/iai.00687-13 · 2013 · External reference
10.1093/nar/gkp851
10.1093/nar/gkp851 · External reference
10.1186/1471-2164-12-215
10.1186/1471-2164-12-215 · External reference
Identification of “preferred” human kinase inhibitors for sleeping sickness lead discovery. Are some kinases better than others for inhibitor repurposing?
10.1021/acsinfecdis.5b00136 · 2016 · External reference
Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi
10.1186/1471-2164-6-127 · 2005 · External reference
10.1186/1471-2164-5-79
10.1186/1471-2164-5-79 · External reference
10.1016/0166-6851(91)90091-j
10.1016/0166-6851(91)90091-j · External reference
10.1128/ec.00366-08
10.1128/ec.00366-08 · External reference
10.1074/mcp.m800556-mcp200
10.1074/mcp.m800556-mcp200 · External reference
Unresolved reference
2013 · External reference
Unresolved reference
2013 · External reference
Unresolved reference
1995 · External reference
Unresolved reference
2006 · External reference
Molecular & biochemical parasitology casein kinase 1 isoform 2 is essential for bloodstream form Trypanosoma brucei contin cytoadherence plasmodium falciparum infected red blood cells after
2009 · External reference
Pairwise knockdowns of cdc2-related kinases (CRKs) in Trypanosoma brucei identified the CRKs for G 1 / S and G 2 / M transitions and demonstrated distinctive Cytokinetic regulations between two developmental stages of the
2005 · External reference
10.1128/aac.00364-08
10.1128/aac.00364-08 · External reference
10.1111/j.1365-2958.2007.05866.x
10.1111/j.1365-2958.2007.05866.x · External reference
10.1016/s0167-4781(01)00240-8
10.1016/s0167-4781(01)00240-8 · External reference
Biochimica et Biophysica Acta Leishmania donovani Aurora kinase : a promising therapeutic target against visceral leishmaniasis
10.1016/j.bbagen.2016.06.005 · 2016 · External reference
NIH Public
2014 · External reference
Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery
10.1039/c4md00045e · 2014 · External reference
10.1242/jcs.056465
10.1242/jcs.056465 · External reference
10.1128/mcb.00478-09
10.1128/mcb.00478-09 · External reference
10.1016/j.ijpara.2006.06.013
10.1016/j.ijpara.2006.06.013 · External reference
10.1128/aac.02022-13
10.1128/aac.02022-13 · External reference
10.1046/j.1365-2958.1996.00136.x
10.1046/j.1365-2958.1996.00136.x · External reference
10.1016/s0166-6851(01)00220-1
10.1016/s0166-6851(01)00220-1 · External reference
Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase
2004 · External reference
10.1002/cmdc.201100344
10.1002/cmdc.201100344 · External reference
10.1371/journal.pntd.0001033
10.1371/journal.pntd.0001033 · External reference
2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro
10.1016/j.bmcl.2015.04.030 · 2015 · External reference
Unresolved reference
2011 · External reference
6-Br-5methylindirubin-3’oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis
10.1016/j.ijpara.2009.04.005 · 2009 · External reference
10.1186/1756-3305-7-234
10.1186/1756-3305-7-234 · External reference
Trypanosoma brucei: two mitogen activated protein kinase kinases are dispensable for growth and virulence of the bloodstrean form
10.1016/j.exppara.2011.03.001 · 2011 · External reference
Interacting protein kinases involved in the regulation of
2006 · External reference
10.1016/j.ijpara.2010.02.004
10.1016/j.ijpara.2010.02.004 · External reference
In silico repositioning-Chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni
10.1371/journal.pntd.0003435 · 2015 · External reference
10.1016/s1470-2045(12)70270-x
10.1016/s1470-2045(12)70270-x · External reference
10.1158/1078-0432.ccr-10-2200
10.1158/1078-0432.ccr-10-2200 · External reference
10.1038/nrm1401
10.1038/nrm1401 · External reference
NMS-P937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignancies
10.1158/1535-7163.mct-11-0765 · 2012 · External reference
Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence: implications for therapy
10.4161/cc.9.16.12732 · 2010 · External reference
Preclinical evaluation of the novel multi-targeted agent R1530
10.1007/s00280-011-1608-x · 2011 · External reference
10.1038/nrd4683
10.1038/nrd4683 · External reference
